OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use
Sign Up to like & getrecommendations! Published in 2020 at "CNS Drugs"
DOI: 10.1007/s40263-020-00776-8
Abstract: OnabotulinumtoxinA (Botox®; a formulation of botulinum toxin type A (BoNT/A)] is indicated for the prevention of headaches in adults with chronic migraine (CM) in numerous countries, including those of Europe. In clinical trials, intramuscular administration… read more here.
Keywords: migraine; profile use; bont; onabotulinumtoxina chronic ... See more keywords
OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Neurology"
DOI: 10.1111/ene.13523
Abstract: OnabotulinumtoxinA is a treatment specifically approved for the prophylaxis of chronic migraine in adults. The aim of this study was to assess the effectiveness of OnabotulinumtoxinA in chronic migraine after 1 year of treatment in… read more here.
Keywords: study; predictors response; onabotulinumtoxina chronic; migraine predictors ... See more keywords